For the third year in a row, Cardinal Health has recognized Sumitomo Pharma America as a Supply Chain Excellence Best In Class Award winner. In addition, Steve McAlpine, National Account Director – Trade, was named the Brand Trade Representative of the Year. Congratulations to Steve and the entire SMPA team for these outstanding achievements! Together, they exemplify our values, including to “Deliver for Patients” and “Engage as One Team.” #Sumitomolife
Sumitomo Pharma America, Inc.
制药业
Marlborough,Massachusetts 67,041 位关注者
We are united in our mission to deliver patient-needed therapies sooner.
关于我们
Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in oncology, urology, women’s health, rare disease, cell and gene therapies and psychiatry and neurology. SMPA was formed through the consolidation of Sumitomo Pharma’s U.S. affiliate companies including Sunovion Pharmaceuticals, Inc., Sumitomo Pharma America Holdings, Inc., Sumitomo Pharma Oncology, Inc., Sumitovant Biopharma, Inc., Myovant Sciences, Inc., Urovant Sciences, Inc. and Enzyvant Therapeutics, Inc. SMPA is a Sumitomo Pharma company. Community Guidelines: https://www.us.sumitomo-pharma.com/social-media/index.html
- 网站
-
https://us.sumitomo-pharma.com
Sumitomo Pharma America, Inc.的外部链接
- 所属行业
- 制药业
- 规模
- 1,001-5,000 人
- 总部
- Marlborough,Massachusetts
- 类型
- 私人持股
- 创立
- 2023
地点
-
主要
84 Waterford Drive
US,Massachusetts,Marlborough,01752
Sumitomo Pharma America, Inc.员工
动态
-
We are announcing three presentations at the 66th American Society of Hematology (ASH) Annual Meeting & Exposition taking place in San Diego, California from December 7-10, 2024. The presentations will include new clinical data supporting an investigational?small molecule being researched for the treatment of relapsed/refractory myelofibrosis (MF), and an investigational oral small molecule being researched for relapsed/refractory acute leukemia. #ASH2024 You can read more here: https://bit.ly/3YCMC8v
-
It’s Compliance Week at Sumitomo Pharma America, Inc. The theme is “One Team. One PACT,” where we will raise awareness of ethics and compliance and recognize key partners along with celebrating our corporate mission and values. Patients are the priority Be Accountable? Conduct business with integrity and Transparency?
-
-
The support of adults caring for parents or grandparents in need, spouses caring for partners, siblings for siblings, or parents or grandparents caring for children with disabilities or medical conditions, like congenital athymia, does not go unnoticed. We want to extend our sincerest thanks and gratitude to the work of family caregivers across the country. References: 1. https://lnkd.in/gaeMjtPW.
-
-
Happy Halloween #sumitomolife
-
-
Sumitomo Pharma America is focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need spanning oncology, urology, women’s health, rare disease, psychiatry & neurology and cell & gene therapies. We are hiring so come join us. #Sumitomolife https://lnkd.in/gfZNvWke
-
-
SMPA is proud to highlight our own @JohannaRossell, SVP and GM, Rare Disease as she presents today at Reuter’s Pharma Customer Engagement USA 2024 event. She will offer insights on commercializing innovative therapies through academia partnerships with multi-functional teams. Make sure to check out the session if you’re in attendance! https://bit.ly/3NnITWU #REcustomerUSA
-
-
It’s #DepressionAwarenessMonth, an important opportunity to recognize that mental health is a critical part of our physical health. Together with our colleagues, neighbors and friends, we hope to reduce the stigma associated with depression and create safe spaces for open conversations about a complex condition that affects millions of people – often silently. If you or someone you love needs support, you can call or text 988 to reach the Suicide and Crisis Lifeline, 24 hours a day. #MentalHealthMatters
-
-
October is #LGBTQHistoryMonth, and Sumitomo Pharma America is proud to celebrate the history and achievements of the LGBTQIA+ community, and the many contributions of LGBTQIA+ caregivers, providers and SMPA colleagues who help deliver differentiated medicines that address patient needs. ????? Together, let’s honor those who’ve fought for progress and continue to advocate for an inclusive future where everyone is valued. #CelebrateDiversity #StandForEquality #Sumitomolife
-
-
Join us in celebration of #IndigenousPeoplesDay and recognize the lasting contributions of Indigenous communities to our collective knowledge and daily life. Indigenous communities around the world are pioneers of medicine and healing – a legacy we hope to build on as we accelerate drug development in key areas of unique and unmet medical need. Today and every day, we reflect on the history of Indigenous cultures, and seek to uplift their voices in our workplaces – and beyond. #IndigenousEmpowerment #Sumitomolife
-